OGC
NVO

One68 Global Capital’s Novo Nordisk NVO Stock Holding History

One68 Global Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$588K Buy
+16,830
New +$582K 1.18% 20

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

One68 Global Capital's NVO Position: Q4 2020 in Review

One68 Global Capital opened a new position in Novo Nordisk (NVO) in Q4 2020: 16,830 shares worth $588K. The stake represents 1.18% of the portfolio and ranks #20 among its holdings.

702 funds tracked by Wall St. Rank hold NVO as of Q4 2020.

  • One68 Global Capital held 16,830 shares of Novo Nordisk worth $588K as of Q4 2020.
  • Novo Nordisk was a new One68 Global Capital position in Q4 2020.
  • Novo Nordisk made up 1.18% of One68 Global Capital's portfolio in Q4 2020, its #20 holding.
  • 702 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.